Integrated scientific writing, brand, technology, channel and BI support for Hyderabad's pharma ecosystem, India's bulk-drug capital and Genome Valley.
Hyderabad is the 'Bulk Drug Capital of India' and home to Genome Valley, the country's first organised life-sciences cluster. Dr. Reddy's, Aurobindo, Hetero, Divi's, Granules and MSN are all based here, alongside one of the world's densest concentrations of API manufacturing, CROs and contract research talent.
Why it matters: Hyderabad accounts for roughly a third of India’s bulk-drug (API) production.
Submission-ready publications and compelling medical affairs assets.
ExploreTherapy-aware brand campaigns and field force tools, from brief to deployment.
ExploreThree proprietary tools that eliminate high-friction activities in pharma writing and PV operations.
ExploreStructured, trackable engagement programs that connect field investments to prescription outcomes.
ExplorePredictive insights and end-to-end automation for pharma commercial operations.
Explore